Published on 24 Jul 2023 on Zacks via Yahoo Finance
BD (BDX) Receives FDA Nod to Address Critical Infusion Needs
Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for its updated BD Alaris Infusion System. This is expected to enable both remediation and a return to full commercial operations for the comprehensive infusion system in the United States.
The latest FDA clearance is expected to significantly solidify its foothold in the infusion system market in the United States and strengthen its Medical segment.
Few Words on the Infusion System